Market Alert: COVID-19 Resurgence Renewed Pressure on Global Financial Markets

Beamtree Expands into UK Healthcare with NHS Partnership

May 30, 2025

Beamtree Holdings Limited (ASX: BMT), a global leader in healthcare analytics and AI-driven decision support, is entering the UK market through a strategic alliance with the NHS Confederation. This five-year partnership, with an optional five-year extension, introduces the Evolve Collaborative—an initiative to deliver predictive analytics and benchmarking tools to NHS trusts across England, Wales, and Northern Ireland. With pricing set at £50,000 per hospital trust annually, Beamtree will initially receive the first £500,000 to offset platform setup costs. The launch is scheduled for late 2025, with full-scale operations by early 2026. Beamtree will invest approximately AU$1.5 million over FY25–FY26 in this venture. Evolve offers access to advanced analytics, comparative benchmarking, and peer-led learning communities, aligning with Beamtree's broader mission to enhance global healthcare outcomes through data-driven insights across diagnostics, clinical support, data quality, and knowledge networks

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com